Related Experiment Video
Updated: Jul 16, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hepatitis C and HIV
Jenny O Smith1, Richard K Sterling
1Section of Hepatology, Virginia Commonwealth University Medical Center, 1200 East Broad Street, Room 1492, Box 908341, Richmond, VA 23298-0341, USA.
Insights
Coinfection with Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) is common. While HIV treatments have improved, liver disease mortality is rising in coinfected patients, necessitating better management strategies.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) coinfection presents significant global health challenges.
- Shared transmission routes contribute to the high prevalence of HIV-HCV coinfection.
- Advances in highly active antiretroviral therapy (HAART) have reduced HIV-related mortality but increased the relative burden of liver disease.
Purpose of the Study:
- To address the rising incidence of liver-related mortality in patients coinfected with HIV and HCV.
- To optimize the evaluation and management strategies for HIV-HCV coinfected individuals.
- To highlight the need for continued research in managing coinfection.
Main Methods:
- Literature review focusing on epidemiological data and clinical outcomes.
- Analysis of trends in mortality rates associated with HIV and HCV coinfection.
- Synthesis of current research on management protocols.
Main Results:
- Significant increase in liver-related mortality observed in HIV-HCV coinfected patients.
- Progression of liver disease is accelerated in the presence of coinfection.
- Current management strategies require optimization to mitigate liver complications.
Conclusions:
- HIV-HCV coinfection poses a growing threat due to increased liver disease progression and mortality.
- Enhanced surveillance and tailored treatment approaches are crucial for this patient population.
- Further research is essential to improve long-term outcomes for coinfected individuals.
Abstract:
HIV and hepatitis C virus (HCV) are global health concerns, and coinfection with these viruses is common due to shared routes of transmission. Mortality rates from AIDS and HIV-associated opportunistic infections have decreased since the institution of highly active antiretroviral therapy, but the incidence of liver-related mortality in coinfected patients has subsequently risen significantly. This increase in progression of liver disease and its subsequent increased mortality have spurred research into the optimization of evaluation and management of the HIV-HCV coinfected patient.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Sexually Transmitted Infections
Retrovirus Life Cycles
Cytomegalovirus Disease
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
